Stay updated on Nivolumab and Cyclophosphamide for R/R AML Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Access to the study record is now blocked by a 403 Forbidden error page, replacing the study details and navigation. This indicates an error state rather than an actual content update.
    Difference
    19%
    Check dated 2026-09-19T20:21:20.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision: v3.6.6 appears on the page, replacing v3.6.5. This indicates a minor update to page metadata or formatting without altering the study details, eligibility criteria, or outcomes.
    Difference
    0.1%
    Check dated 2026-08-29T20:48:43.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision: v3.6.5 was added, and multiple Study Documents entries (Informed Consent Form, Study Protocol and SAP, and related items) were removed from the page.
    Difference
    18%
    Check dated 2026-08-08T16:18:03.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.3 to v3.6.4, indicating a new edition of the page. This reflects a minor update to the document rather than a substantive modification to the study details.
    Difference
    0.1%
    Check dated 2026-07-25T08:19:56.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Revision label on the page changed from v3.6.2 to v3.6.3. This reflects a minor update to the study record's documentation and does not change the study content or participant-facing information.
    Difference
    0.1%
    Check dated 2026-07-03T21:51:39.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.0 to v3.6.2, reflecting a minor documentation update to the study page and its linked materials.
    Difference
    0.1%
    Check dated 2026-06-26T19:45:09.000Z thumbnail image

Stay in the know with updates to Nivolumab and Cyclophosphamide for R/R AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page.